Argatroban is indicated for:
Population group: both men and women, only adults (18 years old or older)
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: both men and women, only adults (18 years old or older)
Argatroban is indicated for anticoagulation in adult patients with heparin-induced thrombocytopenia type II who require parenteral antithrombotic therapy. The diagnosis should be confirmed by the HIPAA (heparin induced platelet activation assay) or an equivalent test. However, such confirmation must not delay the start of treatment. 1
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Argatroban is contraindicated in the following cases: